Form 4: Myriad Genetics SVP Margaret Ancona Reports Stock Sale
SEC Form 4 Filing
Margaret Ancona, SVP and Chief of Staff at Myriad Genetics, sold 11,538 shares of common stock at $27.82 per share on August 21, 2024.
Summary
- On August 21, 2024, Margaret Ancona, the SVP and Chief of Staff of Myriad Genetics Inc. (MYGN), sold 11,538 shares of the company's common stock.
- The sale price was $27.82 per share.
- Following the transaction, Ancona directly owns 79,366 shares of Myriad Genetics.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by an insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. It is difficult to assess the impact of this sale without more context.
Stakeholder Impact
- The sale of shares by a company insider could be perceived negatively by some shareholders, although it is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 08/21/2024 | Date of stock sale transaction |
| 08/23/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.